Bioinformatics prediction of HIV coreceptor usage

Nature Biotechnology

Volumn 25, Issue 12, 2007, Pages 1407-1410

  Lengauer, Thomas ^a   Sander, Oliver ^a   Sierra, Saleta ^b   Thielen, Alexander ^a   Kaiser, Rolf ^b  

^a MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); AMD 070; ANTIVIRUS AGENT; CELSENTRI; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ENFUVIRTIDE; INTEGRASE INHIBITOR; ISENTRESS; MARAVIROC; RALTEGRAVIR; SELZENTRY; TNX 355; UNCLASSIFIED DRUG; VICRIVIROC;

ALGORITHM; BIOINFORMATICS; CLINICAL TRIAL; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PRIORITY JOURNAL; PROGNOSIS; TECHNOLOGY; UNSPECIFIED SIDE EFFECT;

ANTIVIRAL AGENTS; BINDING SITES; COMPUTATIONAL BIOLOGY; DRUG DESIGN; HIV; PROTEIN BINDING; RECEPTORS, HIV;

EID: 36849083542     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1371     Document Type: Note

References (31)

1. Lengauer, T. & Sing, L. Nat. Rev. Microbiol. 4, 790-797 (2006).
2. Opar, A. Nat. Rev. Drug Discov. 6, 258-259 (2007).
3. Cahn, P. & Sued, O. Lancet 369, 1235-1236 (2007).
4. Berger, E.A., Murphy, P.M. & Farber, J.M. Annu. Rev. Immunol. 17, 657-700 (1999).
5. Wolinsky, S.M. et al. Science 255, 1134-1137 (1992).
6. Novembre, J., Galvani, A.P. & Slatkin, M. PLoS Biol. 3, e339 (2005).
7. Regoes, R.R. & Bonhoeffer, S. Trends Microbiol. 13, 269-277 (2005).
8. Westby, M. & van der Ryst, E. Antivir. Chem. Chemother. 16, 339-354 (2005).
9. Rusconi, S. et al. Curr. Top. Med. Chem. 7, 1273-1289 (2007).
10. Dorr, P. et al. Antimicrob. Agents Chemother. 49, 4721-4732 (2005).
11. Moore, J.P. et al. AIDS Res. Hum. Retroviruses 20, 111-126 (2004).
12. Mori, J. et al. Antivir. Ther. 12, S12 (2007).
13. Schuitemaker, H. et al. J. Virol. 66, 1354-1360 (1992).
14. Trouplin, V. et al. J. Virol. 75, 251-259 (2001).
15. Coakley, E., Petropoulos, C.J. & Whitcomb, J.M. Curr. Opin. Infect. Dis. 18, 9-15 (2005).
16. Skrabal, K. et al. J. Clin. Microbiol. 45, 279-284 (2007).
17. Jensen, M.A. & van't Wout, A.B. AIDS Rev. 5, 104-112 (2003).
18. Lehmann, C. et al. J. Clin. Virol. 37, 300-304 (2006).
19. Pastore, C. et al. J. Virol. 80, 750-758 (2006).
20. Sing, T., Beerenwinkel, N. & Lengauer, T. in Proceedings of the 1st International Workshop on ROC Analysis in Artificial Intelligence (ROCAI 2004) (eds. Hernández-Orallo, J. et al.) 89-96 (IOS Press, Amsterdam, 2004).
21. Pillai, S. et al. AIDS Res. Hum. Retroviruses 19, 145-149 (2003).
22. Jensen, M.A. et al. J. Virol. 77, 13376-13388 (2003).
23. Poveda, E. et al. AIDS 21, 1487-1490 (2007).
24. Sing, T. et al. Antivir. Ther. 12, 1097-1106 (2007).
25. Low, A.J. et al. AIDS 21, F17-F24 (2007).
26. Sander, O. et al. PLoS Comput. Biol. 3, e58 (2007).
27. Wilkin, T.J. et al. Clin. Infect. Dis. 44, 591-595 (2007).
28. Brumme, Z.L. et al. J. Infect. Dis. 192, 466-474 (2005).
29. Lewis, M. et al. Antivir. Ther. 12, S65 (2007).
30. Huang, C.C. et al. Science 310, 1025-1028 (2005).
31. Liu, S., Fan, S. & Sun, Z. J. Mol. Model. 9, 329-336 (2003).